Predictors of Six-Month Mortality in BNP-Matched Acute Heart Failure Patients

American Journal of Cardiology

Volumn 116, Issue 5, 2015, Pages 744-748

  Lourenço, Patrícia ^a   Ribeiro, Ana ^a   Pintalhão, Mariana ^a,b   Silva, Sérgio ^a,b   Bettencourt, Paulo ^a,b  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; UREA; BIOLOGICAL MARKER;

ACUTE HEART FAILURE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATRIAL FIBRILLATION; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; UREA BLOOD LEVEL; ACUTE DISEASE; BLOOD; EPIDEMIOLOGY; HEART FAILURE; MORTALITY; PORTUGAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PORTUGAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84952872372     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.046     Document Type: Article

References (30)

1. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, M. Santalo-Bel, Y.M. Pinto, and M. Richards NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
2. R. Latini, S. Masson, M. Wong, S. Barlera, E. Carretta, L. Staszewsky, T. Vago, A.P. Maggioni, I.S. Anand, L.B. Tan, G. Tognoni, J.N. Cohn, and F.T. Val-He Incremental prognostic value of changes in B-type natriuretic peptide in heart failure Am J Med 119 2006 e23 e30
3. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Breathing Not Properly Multinational Study I. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
4. S. Masson, R. Latini, I.S. Anand, S. Barlera, L. Angelici, T. Vago, G. Tognoni, J.N. Cohn, and F.T. Val-He Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
5. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, R.J. Rodeheffer, J.C. Burnett Jr., and A.S. Jaffe Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257
6. M. Bohm, K. Swedberg, M. Komajda, J.S. Borer, I. Ford, A. Dubost-Brama, G. Lerebours, L. Tavazzi SHIFT Investigators Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
7. T. Takada, Y. Sakata, S. Miyata, J. Takahashi, K. Nochioka, M. Miura, S. Tadaki, H. Shimokawa CHART-2 Investigators Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study Eur J Heart Fail 16 2014 309 316
8. M. Banach, V. Bhatia, M.A. Feller, M. Mujib, R.V. Desai, M.I. Ahmed, J.L. Guichard, I. Aban, T.E. Love, W.S. Aronow, M. White, P. Deedwania, G. Fonarow, and A. Ahmed Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure Am J Cardiol 107 2011 1208 1214
9. T.T. Lee, J. Chen, D.J. Cohen, and L. Tsao The association between blood pressure and mortality in patients with heart failure Am Heart J 151 2006 76 83
10. J.P. Araujo, P. Lourenco, A. Azevedo, F. Frioes, F. Rocha-Goncalves, A. Ferreira, and P. Bettencourt Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review J Card Fail 15 2009 256 266
11. J.W. Petersen, and G.M. Felker Inflammatory biomarkers in heart failure Congest Heart Fail 12 2006 324 328
12. S.D. Anker, P. Ponikowski, S. Varney, T.P. Chua, A.L. Clark, K.M. Webb-Peploe, D. Harrington, W.J. Kox, P.A. Poole-Wilson, and A.J. Coats Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
13. P. Lourenco, S. Silva, F. Frioes, M. Alvelos, M. Amorim, M. Couto, P. Torres-Ramalho, J.T. Guimaraes, J.P. Araujo, and P. Bettencourt Low prealbumin is strongly associated with adverse outcome in heart failure Heart 100 2014 1780 1785
14. M. Rauchhaus, A.L. Clark, W. Doehner, C. Davos, A. Bolger, R. Sharma, A.J. Coats, and S.D. Anker The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 42 2003 1933 1940
15. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Stromberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, K. Swedberg ESC Committee for Practice Guidelines (CPG) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
16. J. Muntwyler, G. Abetel, C. Gruner, and F. Follath One-year mortality among unselected outpatients with heart failure Eur Heart J 23 2002 1861 1866
17. P.A. Poole-Wilson, B.F. Uretsky, K. Thygesen, J.G. Cleland, B.M. Massie, L. Ryden Atlas Study Group Assessment of treatment with l, survival. Mode of death in heart failure: findings from the ATLAS trial Heart 89 2003 42 48
18. K. Kalantar-Zadeh, G. Block, T. Horwich, and G.C. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444
19. K. Kalantar-Zadeh, S.D. Anker, T.B. Horwich, and G.C. Fonarow Nutritional and anti-inflammatory interventions in chronic heart failure Am J Cardiol 101 2008 89E 103E
20. D. King, M.L. Smith, T.J. Chapman, H.R. Stockdale, and M. Lye Fat malabsorption in elderly patients with cardiac cachexia Age Ageing 25 1996 144 149
21. J. Niebauer, H.D. Volk, M. Kemp, M. Dominguez, R.R. Schumann, M. Rauchhaus, P.A. Poole-Wilson, A.J. Coats, and S.D. Anker Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353 1999 1838 1842
22. P. Cialdella, D. Pedicino, M. Gustapane, P. Santangeli, M.L. Narducci, G. Pelargonio, E. Basile, A.F. Giglio, V. Pazzano, N. Vitulano, and F. Bellocci Inflammatory markers in heart failure: hype or hope? J Cardiovasc Med (Hagerstown) 14 2013 342 350
23. J.D. Hosenpud, S.M. Campbell, and D.J. Mendelson Interleukin-1-induced myocardial depression in an isolated beating heart preparation J Heart Transplant 8 1989 460 464
24. K. Kinugawa, T. Takahashi, O. Kohmoto, A. Yao, T. Aoyagi, S. Momomura, Y. Hirata, and T. Serizawa Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes Circ Res 75 1994 285 295
25. T. Yokoyama, M. Nakano, J.L. Bednarczyk, B.W. McIntyre, M. Entman, and D.L. Mann Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes Circulation 95 1997 1247 1252
26. O. Zimmermann, M. Bienek-Ziolkowski, B. Wolf, M. Vetter, R. Baur, V. Mailander, V. Hombach, and J. Torzewski Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein? Basic Res Cardiol 104 2009 591 599
27. J. Kjekshus, P. Dunselman, M. Blideskog, C. Eskilson, A. Hjalmarson, J.V. McMurray, F. Waagstein, H. Wedel, P. Wessman, J. Wikstrand, and C.S. Group A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics Eur J Heart Fail 7 2005 1059 1069
28. E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, J.T. Willerson Anti-TNF Therapy Against Congestive Heart Failure Investigators Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy against Congestive Heart Failure (ATTACH) trial Circulation 107 2003 3133 3140
29. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, W.S. Colucci, J. Djian, H. Drexler, A. Feldman, L. Kober, H. Krum, P. Liu, M. Nieminen, L. Tavazzi, D.J. van Veldhuisen, A. Waldenstrom, M. Warren, A. Westheim, F. Zannad, and T. Fleming Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
30. R.A. de Boer, L.B. Daniels, A.S. Maisel, and J.L. Januzzi Jr. State of the art: newer biomarkers in heart failure Eur J Heart Fail 2015 http://dx.doi.org/10.1002/ejhf.273. [Epub ahead of print]